M J Galindo - JoVE Visualize

Showing results (11-20 of 19) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 19 results.

HIV Medicine|May 20, 2008

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot studyJ M Llibre, A Bonjoch, J Iribarren, et al.

HIV Medicine|February 20, 2007

Cervical lipomatosis in HIV-infected patients: a case-control studyR Palacios, M J Galindo, J A Arranz, et al.

HIV Medicine|April 5, 2023

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119R Palacios, C Gómez-Ayerbe, J L Casado, et al.

HIV Medicine|September 30, 2009

The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.

The Journal of Antimicrobial Chemotherapy|June 26, 2019

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)M J Pérez Elías, B Alejos, M J Vivancos, et al.

Nutricion Hospitalaria|April 10, 2007

Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patientR Polo, C Gómez-Candela, C Miralles, et al.

HIV Medicine|August 2, 2016

Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.

The Lancet. HIV|June 9, 2025

Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, José L Blanco, Mar Masia, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.

Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 19 results.

HIV Medicine|May 20, 2008

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot studyJ M Llibre, A Bonjoch, J Iribarren, et al.

HIV Medicine|February 20, 2007

Cervical lipomatosis in HIV-infected patients: a case-control studyR Palacios, M J Galindo, J A Arranz, et al.

HIV Medicine|April 5, 2023

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119R Palacios, C Gómez-Ayerbe, J L Casado, et al.

HIV Medicine|September 30, 2009

The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patientsI Suarez-Lozano, P Viciana, J-R Lacalle, et al.

The Journal of Antimicrobial Chemotherapy|June 26, 2019

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)M J Pérez Elías, B Alejos, M J Vivancos, et al.

Nutricion Hospitalaria|April 10, 2007

Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patientR Polo, C Gómez-Candela, C Miralles, et al.

HIV Medicine|August 2, 2016

Very low level viraemia and risk of virological failure in treated HIV-1-infected patientsR Teira, F Vidal, P Muñoz-Sánchez, et al.

The Lancet. HIV|June 9, 2025

Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, José L Blanco, Mar Masia, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.

Pageof 2